You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Medtronic
Merck
Harvard Business School
McKinsey

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

ZILRETTA Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Zilretta, and when can generic versions of Zilretta launch?

Zilretta is a drug marketed by Flexion Theraps Inc and is included in one NDA. There are two patents protecting this drug.

This drug has forty-seven patent family members in twenty countries.

The generic ingredient in ZILRETTA is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Drug patent expirations by year for ZILRETTA
Drug Prices for ZILRETTA

See drug prices for ZILRETTA

Recent Clinical Trials for ZILRETTA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Austin V StonePhase 2
Flexion Therapeutics, Inc.Phase 1
University of North Carolina, Chapel HillPhase 1

See all ZILRETTA clinical trials

US Patents and Regulatory Information for ZILRETTA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Flexion Theraps Inc ZILRETTA triamcinolone acetonide FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR 208845-001 Oct 6, 2017 RX Yes Yes   Start Trial   Start Trial   Start Trial
Flexion Theraps Inc ZILRETTA triamcinolone acetonide FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR 208845-001 Oct 6, 2017 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Flexion Theraps Inc ZILRETTA triamcinolone acetonide FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR 208845-001 Oct 6, 2017 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Medtronic
Merck
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.